ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Regen BioPharma Files New Composition of Matter Patent Application
europeanpharmaceuticalreview
September 10, 2018Regen BioPharma has filed a patent application covering composition of matter and methods of use related to molecules identified in its small molecule program that activate NR2F6 ("Small Molecule Agonists and Antagonists of NR2F6 Activity in Humans").
Pharma Sources Insight July 2025
